Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
CJC-1131, a long acting GLP-1 analog, safely normalizes post-prandial glucose excursion and fasting glycemia in type 2 diabetes mellitus [abstract]
The conclusion in the prescribing information is unambiguous: "similar exposure" is achieved regardless of which approved site is used
Thats the key finding of new study by Harvard University economics professor Rebecca Diamond, who told Bloomberg News the research was inspired by an offhand comment from a female friend about how people treated her differently after she went on a GLP-1
BioWorld Analysis and data insight Regulatory Cardiovascular Diabetes Endocrine/metabolic Neurology/psychiatric Obesity Peptide Asia-Pacific China U.S
